Intravenous albumin in treatment of acute on chronic liver failure: Can it be an option for resource constrained situation
Introduction The Asian Pacific Association for the Study of the Liver (APASL) defines ACLF as an acute hepatic insult manifesting as jaundice (serum bilirubin >5mg/dl) and coagulopathy (INR>1.5) complicated within 4 weeks by clinical ascites and/or encephalopathy in patients with previously diagnosed or undiagnosed chronic liver disease, associated with high 28-day mortality {1}. The etiology … Read more